Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 29 March 2021. Karen Burke.

Executive Summary

A US FDA panel discussed ways to fight adverse events associated with dermal fillers. The agency’s suggestion that filler labeling incorporate an injection information card for patients to take home drew support from panelist Karen Burke, a dermatology professor at Mount Sinai Medical Center.

“We all have had patients who came to us with nodules and don’t know what was injected and are kind of vague about when it was. I think this would be so great because they’d at least know what they had, and we’d know what we’re treating.” – Karen Burke, professor of dermatology, Mount Sinai Medical Center

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts